Karyopharm Therapeutics (25K.F) Q4 2024 Earnings

Nov 5Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.31
-0.27
-0.23
-0.18

Details

Expected EPS
-0.2411975832
Actual EPS
-0.238576
Surprise EPS
0
Surprise Percent
+1.09%

Description

⁨Karyopharm Therapeutics⁩ (⁦25K.F⁩) has reported earnings of ⁦-0.238576⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts